| scholarly article | Q13442814 |
| P2093 | author name string | Jung-Joon Min | |
| Hyunju Kim | |||
| Daejin Lim | |||
| Hyon E Choy | |||
| Jae-Ho Jeong | |||
| Jae Jun Song | |||
| Jong Hyun Choi | |||
| Kyong-Cheol Ko | |||
| Kwang Soo Kim | |||
| Minsang Shin | |||
| P2860 | cites work | miR-200 enhances mouse breast cancer cell colonization to form distant metastases | Q21091183 |
| Characterization of the Erwinia carotovora pelB gene and its product pectate lyase | Q24680141 | ||
| Advances in anticancer immunotoxin therapy | Q28085551 | ||
| Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium | Q30491729 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors | Q45882843 | ||
| Immune response induced by Salmonella typhimurium defective in ppGpp synthesis | Q46852567 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. | Q53479014 | ||
| Immunotoxins made with a recombinant form of Pseudomonas exotoxin A that do not require proteolysis for activity | Q70523819 | ||
| Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration | Q72132396 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells | Q33727779 | ||
| Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy | Q33731187 | ||
| Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
| EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells | Q33758468 | ||
| Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer | Q33925546 | ||
| An EGFR targeted PET imaging probe for the detection of colonic adenocarcinomas in the setting of colitis | Q33935480 | ||
| Secretory and extracellular production of recombinant proteins using Escherichia coli | Q33976034 | ||
| Immunotoxin treatment of cancer | Q34000417 | ||
| Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins | Q34301980 | ||
| A novel balanced-lethal host-vector system based on glmS. | Q34654013 | ||
| A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer | Q35230663 | ||
| Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses | Q35446009 | ||
| Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. | Q35732250 | ||
| Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice. | Q35735164 | ||
| Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
| Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy | Q36189385 | ||
| Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. | Q36191597 | ||
| Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging | Q37118741 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium | Q37451801 | ||
| Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin | Q37484717 | ||
| Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
| Targeting solid tumors with non-pathogenic obligate anaerobic bacteria | Q37767742 | ||
| Selective killing of tumor cells using EGF or TGF alpha-Pseudomonas exotoxin chimeric molecules | Q37835789 | ||
| Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells | Q38344111 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. | Q38567280 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance | Q39783093 | ||
| Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. | Q39837601 | ||
| Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment | Q40022374 | ||
| In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR. | Q40345495 | ||
| Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation | Q40504400 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| A novel multifunctional cellulolytic enzyme screened from metagenomic resources representing ruminal bacteria. | Q42626056 | ||
| ppGpp-mediated stationary phase induction of the genes encoded by horizontally acquired pathogenicity islands and cob/pdu locus in Salmonella enterica serovar Typhimurium | Q43134134 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| P304 | page(s) | 37550-37560 | |
| P577 | publication date | 2017-04-18 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium | |
| P478 | volume | 8 |
| Q54232801 | Antiviral Immunotoxin Against Bovine herpesvirus-1: Targeted Inhibition of Viral Replication and Apoptosis of Infected Cell. |
| Q58121061 | Co-expression of a Chimeric Protease Inhibitor Secreted by a Tumor-targeted Protects Therapeutic Proteins from Proteolytic Degradation |
| Q64075146 | Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach |
| Q90394569 | Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties |
| Q50024692 | Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review |
| Q90017521 | Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q104280671 | Tweak to Treat: Reprograming Bacteria for Cancer Treatment |
Search more.